Bacteriostatic water with benzyl alcohol is the standard multi-dose diluent for lyophilised peptides and several licensed hormone medicines. The formulation is almost boring in its simplicity: water for injection plus 0.9% (9 mg/mL) benzyl alcohol, nothing else. Yet that single excipient is what allows a vial to be entered repeatedly over 28 days, and it is also the reason the product carries a hard contraindication in newborns.
This article looks at the ingredient itself: what benzyl alcohol is, how it stops bacteria growing, why 0.9% is the concentration used, how the body handles it, and where the safety limits lie. The comparison with unpreserved water is in bacteriostatic water vs sterile water; the practical maths is in the reconstitution guide.
What benzyl alcohol is
Benzyl alcohol (chemical formula C7H8O) is an aromatic alcohol: a benzene ring attached to a single hydroxymethyl (CH2OH) group. It is a colourless liquid with a faint sweet smell, moderately soluble in water (about 4% at room temperature, comfortably above the 0.9% used in diluents). It occurs naturally in jasmine and other essential oils and is manufactured at scale for cosmetics, foods and medicines.
In pharmaceuticals it does three jobs. It is a preservative in multi-dose injectables, oral liquids and topical products; a co-solvent that helps dissolve poorly soluble drugs; and a mild local anaesthetic, which is why it is added to some intramuscular and intravenous formulations to reduce injection-site pain [1]. In bacteriostatic water, only the first role matters.
How benzyl alcohol works as a preservative
Benzyl alcohol is bacteriostatic rather than bactericidal at the concentrations used in diluents: it inhibits growth rather than sterilising. Like other aromatic alcohols and phenolic preservatives, its activity is attributed to its ability to partition into the lipid bilayer of the bacterial cell membrane. Once there it increases membrane fluidity and permeability, disrupting the membrane’s function as a barrier and interfering with membrane-bound enzymes and transport. Cells leak, cannot maintain their internal environment, and stop dividing.
This membrane-directed mechanism is why benzyl alcohol works across a broad range of organisms rather than targeting one metabolic pathway, and why it is described as bacteriostatic: at 0.9% it stops growth but does not reliably kill everything already present. It is also why the product is sold in glass vials with rubber stoppers, since anything that absorbs or binds the molecule reduces the amount left in solution to do its job.
Why 0.9% benzyl alcohol water and not another concentration
A preservative concentration has to satisfy two opposing requirements: high enough to pass antimicrobial effectiveness testing, and low enough to be tolerated on repeated injection and to leave the dissolved drug alone. Benzyl alcohol is used as an antimicrobial agent in injectable formulations at concentrations of roughly 0.9% to 2% [2]. At 0.9% (9 mg/mL) the United States Pharmacopeia (USP) product passes the multi-dose requirement; the licensed US product is offered at 0.9% and 1.1% and states that the alcohol is “added as a bacteriostatic preservative” [3].
Going lower would risk failing the 28-day antimicrobial challenge on which the multi-dose beyond-use date rests. Going higher adds no useful margin and raises the benzyl alcohol dose per injection. Nine milligrams per millilitre is modest in absolute terms: a 0.1 mL subcutaneous dose of reconstituted peptide contains about 0.9 mg of benzyl alcohol.
How the body handles benzyl alcohol
Benzyl alcohol is metabolised rapidly. It is oxidised to benzoic acid, which is conjugated with glycine in the liver to form hippuric acid, and hippuric acid is excreted in the urine [1][2]. In adults and older children this pathway has ample capacity for the amounts encountered as an excipient. The European Medicines Agency (EMA) notes that the Scientific Committee on Food assigned benzyl alcohol an acceptable daily intake of 0 to 5 mg/kg body weight [1].
To put the diluent in context: a 70 kg adult receiving a 0.1 mL injection reconstituted with bacteriostatic water is exposed to roughly 0.013 mg/kg of benzyl alcohol, about four hundred times below the 5 mg/kg/day intake figure. Even a full 1 mL injection delivers 9 mg, or about 0.13 mg/kg. The excipient is not the limiting factor in adult subcutaneous use.
Gasping syndrome: the neonatal contraindication
The exception is the newborn, and it is absolute. In 1982 Gershanik and colleagues reported a cluster of deaths in premature infants in a neonatal intensive care unit who had received intravenous catheter flushes and medications preserved with benzyl alcohol [4]. The infants developed metabolic acidosis, gasping respirations, neurological deterioration, cardiovascular collapse and haematological abnormalities; the pattern became known as the gasping syndrome. The EMA’s excipient review states that benzyl alcohol administered intravenously in the range of 100 to 200 mg/kg/day was linked to the syndrome and that most cases were fatal [1].
The mechanism is metabolic rather than a direct toxicity of the alcohol. A US Food and Drug Administration (FDA) pharmacology review explains that premature infants “may be uniquely susceptible” because of an inability to adequately metabolise and excrete benzoic acid, owing to a diminished capacity to form hippuric acid by glycine conjugation [5]. Benzoic acid accumulates, producing the acidosis. Affected infants in the original cluster weighed under 2,500 g and were of 26 to 34 weeks’ gestation [5].
The regulatory response is unambiguous. The US bacteriostatic water label states “NOT FOR USE IN NEONATES” and that “due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used” [3]. The EMA’s excipient guidance sets no threshold below which benzyl alcohol is considered safe in neonates, accepts safe use only in children older than four weeks, and advises against use for more than a week in children under three without medical advice because of the risk of accumulation [1]. No adult diluent decision should be extrapolated to a newborn.
Other adverse effects and interactions
Outside the neonatal setting, benzyl alcohol at diluent concentrations is well tolerated. Hypersensitivity reactions are reported but rare, and at 0.9% the alcohol is more often included to reduce injection pain than to cause it. Whether the preservative affects the dissolved peptide is a formulation question: benzyl alcohol is used with hCG and follitropin in licensed multi-dose products without a stability problem [6][7], and a solution that stays clear can be used within the 28-day window described in how to store bacteriostatic water.
Bacteriostatic water with benzyl alcohol as mixing water for injections
Set against unpreserved sterile water, which is labelled for single use, the 0.9% benzyl alcohol in bacteriostatic water is what earns a vial its 28-day multi-dose life under USP <797> and CDC guidance [8]. For an adult reconstituting a vial that will be entered more than once, it is the appropriate mixing water. For a neonate, or a vial used once and discarded, an unpreserved diluent is the right choice.
Multi-dose vials need a preserved diluent. Baclabs supplies UK-stocked bacteriostatic water with 0.9% benzyl alcohol in 30 mL vials; the reconstitution guide covers concentrations and technique.
Frequently asked questions
Is 0.9% benzyl alcohol safe to inject?
In adults and older children, yes, at the amounts delivered as a diluent excipient. A 0.1 mL subcutaneous dose contains about 0.9 mg of benzyl alcohol, which is metabolised to benzoic acid and excreted as hippuric acid within hours. The product is contraindicated in neonates and premature infants, whose immature metabolism cannot clear benzoic acid.
Why does bacteriostatic water contain benzyl alcohol instead of another preservative?
Benzyl alcohol is broadly active against bacteria at low concentration, chemically stable in water, compatible with a wide range of drugs, and has decades of use in licensed injectables. Alternatives such as metacresol and phenol are used in some manufacturer-supplied solvents, but benzyl alcohol at 0.9% is the pharmacopoeial standard for a general-purpose multi-dose diluent.
What is gasping syndrome?
A fatal toxic reaction in premature infants exposed to benzyl alcohol, described in 1982. It involves metabolic acidosis, gasping breathing, neurological decline and cardiovascular collapse, caused by accumulation of benzoic acid that immature livers cannot conjugate to hippuric acid. It was linked to intravenous exposures around 100 to 200 mg/kg/day and is why benzyl alcohol products are not for use in neonates.
Does benzyl alcohol kill bacteria or just stop them growing?
At 0.9% it is bacteriostatic: it disrupts the bacterial cell membrane enough to stop growth and division, but it does not reliably kill organisms already present and it will not sterilise a contaminated vial. That is why aseptic technique, a swabbed stopper and a fresh needle at every entry remain essential.
Can benzyl alcohol damage the peptide I am reconstituting?
Not in general. Licensed hCG and follitropin multi-dose products are supplied with 0.9% benzyl alcohol diluents and remain stable for 28 to 60 days. Some proteins are sensitive to preservatives in formulation studies, so any vial that turns cloudy or develops particles should be discarded, but for short peptides the preservative is rarely the problem.
References
- Questions and answers on benzyl alcohol used as an excipient in medicinal products for human use (EMA/CHMP/508188/2013). European Medicines Agency, 2017
- Johnson W Jr, Bergfeld WF, Belsito DV, et al. Safety Assessment of Benzyl Alcohol, Benzoic Acid and its Salts, and Benzyl Benzoate. Int J Toxicol 2017. doi:10.1177/1091581817728996. International Journal of Toxicology, 2017
- Bacteriostatic Water for Injection, USP, prescribing information (Hospira). DailyMed, US National Library of Medicine, current label
- Gershanik J, Boecler B, Ensley H, McCloskey S, George W. The gasping syndrome and benzyl alcohol poisoning. N Engl J Med 1982;307(22):1384-8. PubMed, 1982
- Clinical pharmacology review, NDA 022129 (benzyl alcohol): paediatric considerations and gasping syndrome. US Food and Drug Administration
- Pregnyl (chorionic gonadotropin for injection, USP), US prescribing information. DailyMed, US National Library of Medicine
- Gonal-f Multi-Dose (follitropin alfa for injection), US prescribing information. EMD Serono
- Crosswalk of Guidances and Standards for Managing Single- and Multi-Dose Vials (USP <797>, CDC, TJC). American Society of Health-System Pharmacists
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Bacteriostatic water is supplied for reconstitution of substances intended for research and for use as directed by a healthcare professional. Peptides and medicines discussed here may be unlicensed in the UK or prescription-only; consult a qualified clinician before using any medicine. Baclabs does not sell peptides.